Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: maileg who wrote (2381)	7/1/1999 1:42:00 PM
From: Rudy Saucillo	Read Replies (1) \| Respond to of 2742

Hi, Darci. Interesting idea. The name of the company is BioPort, Inc., a private(?) company out of Lansing, MI. There was a TV story about the anthrax vaccine and BioPort within the past few days on the national news or one of the news "magazines." I don't recall where I saw it. In addition to the safety controversy with the vaccine, BioPort apparently is having difficulties with the FDA regarding vaccine production and QC. No details were given except that BioPort is "working closely with the FDA" to resolve the issues. Sounds like a company Naismith should be talking to! Rudy